“The increase in net cash provided by investing activities of $59.2 million in the nine months ended September 30, 2025 , as compared to the prior year, was driven by a decrease in purchases of marketable debt instruments, net of proceeds from maturities of marketable debt instruments, of $58.7 million and a decrease in capital expenditures of $0.5 million .”
“Research and Development Research and Development expenses increased by $1,818,000 in fiscal 2025 as compared to fiscal 2024, primarily due to increases of $1,750,000 in personnel-related expenses mainly from merit increases and the hiring of additional engineering staff.”
“The decrease in gross profit and gross margin for the nine months ended September 30, 2025 , as compared to the prior year, was due primarily to costs related to product mix and tariffs, partially offset by a decrease in indirect manufacturing costs during the nine months ended September 30, 2025 .”